Prof. Ron Ofri of Hebrew University of Jerusalem’s Koret School of Veterinary Medicine has developed a gene therapy that may cure hereditary day blindness, called achromatopsia. People affected by this vision disorder cannot see in bright daylight, can only see in low-light conditions, and have low visual acuity and colorblindness as well. Incidence of the disease varies according to population, genetic background, and rate of marriages between close relatives, with its prevalence in Jerusalem affecting one out of 5,000 individuals.
Comments